SlideShare a Scribd company logo
Issues for Today and Tomorrow Ownership Rights: Patents for Derivatives of the Human Body Larnita Pette May 19, 2009  (Updated  December 2011)
[object Object],[object Object]
How Did We Get Here? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Question of Ownership Rights ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Today’s Situation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Strategies to Protect Donor Rights ,[object Object],[object Object],[object Object],[object Object],[object Object]
Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Genetic Privacy Act  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The Final Report of "Guidelines for Protecting Privacy of Information Stored in Genetic Data Banks" funded by the Ethical, Legal & Social Implications of the Human Genome Project, Office of Energy Research, U.S. Department of Energy, No. DE-FG02-93ER61626. February 28, 1995

More Related Content

What's hot

Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...Stephen Cranwell
 
Utility must be specific, practical
Utility must be specific, practicalUtility must be specific, practical
Utility must be specific, practicalLawrence Kass
 
Ground flour pharmaceuticals lecture 3 value prop
Ground flour pharmaceuticals lecture 3 value propGround flour pharmaceuticals lecture 3 value prop
Ground flour pharmaceuticals lecture 3 value propStanford University
 
Ethics and the Law - Myriad Genetics
Ethics and the Law - Myriad GeneticsEthics and the Law - Myriad Genetics
Ethics and the Law - Myriad Genetics
Klemchuk LLP
 
Fda phacilitate2010final
Fda phacilitate2010finalFda phacilitate2010final
Fda phacilitate2010finalisoasp
 
Gene patenting
Gene patentingGene patenting
Gene patenting
Hina Zamir Noori
 
Frauds in Stem Cell
Frauds in Stem CellFrauds in Stem Cell
Frauds in Stem Cell
Ankita Murmu
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 projectmdragoescu
 
The Case Of Incyte Genomics
The Case Of Incyte GenomicsThe Case Of Incyte Genomics
The Case Of Incyte Genomicsjrstorella
 
20150515 Stennett L - Resume
20150515  Stennett L - Resume20150515  Stennett L - Resume
20150515 Stennett L - ResumeLawrence Stennett
 
Ilene Mizrachi - Opening Plenary
Ilene Mizrachi - Opening PlenaryIlene Mizrachi - Opening Plenary
Ilene Mizrachi - Opening Plenary
Consortium for the Barcode of Life (CBOL)
 
Klevan presentation slides v3
Klevan presentation slides v3Klevan presentation slides v3
Klevan presentation slides v3conniegolden
 

What's hot (12)

Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
Ethical Issues Surrounding Patenting of Human Genes and the Development of Ne...
 
Utility must be specific, practical
Utility must be specific, practicalUtility must be specific, practical
Utility must be specific, practical
 
Ground flour pharmaceuticals lecture 3 value prop
Ground flour pharmaceuticals lecture 3 value propGround flour pharmaceuticals lecture 3 value prop
Ground flour pharmaceuticals lecture 3 value prop
 
Ethics and the Law - Myriad Genetics
Ethics and the Law - Myriad GeneticsEthics and the Law - Myriad Genetics
Ethics and the Law - Myriad Genetics
 
Fda phacilitate2010final
Fda phacilitate2010finalFda phacilitate2010final
Fda phacilitate2010final
 
Gene patenting
Gene patentingGene patenting
Gene patenting
 
Frauds in Stem Cell
Frauds in Stem CellFrauds in Stem Cell
Frauds in Stem Cell
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project
 
The Case Of Incyte Genomics
The Case Of Incyte GenomicsThe Case Of Incyte Genomics
The Case Of Incyte Genomics
 
20150515 Stennett L - Resume
20150515  Stennett L - Resume20150515  Stennett L - Resume
20150515 Stennett L - Resume
 
Ilene Mizrachi - Opening Plenary
Ilene Mizrachi - Opening PlenaryIlene Mizrachi - Opening Plenary
Ilene Mizrachi - Opening Plenary
 
Klevan presentation slides v3
Klevan presentation slides v3Klevan presentation slides v3
Klevan presentation slides v3
 

Similar to Ownership Rights:: Patents for Derivatives of the Human Body

Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
Kirby Drake
 
Stem Cell Ethics .pptx
Stem Cell Ethics .pptxStem Cell Ethics .pptx
Stem Cell Ethics .pptx
Zahraa63902
 
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENESTHE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
Saravanan A
 
Genomics privacy
Genomics privacyGenomics privacy
Genomics privacy
T.J. Kasperbauer
 
Ethics And The Human Genome Project
Ethics And The Human Genome ProjectEthics And The Human Genome Project
Ethics And The Human Genome Project
Nadia Blanchard
 
Nagma(patenting of genes)
Nagma(patenting of genes)Nagma(patenting of genes)
Nagma(patenting of genes)
NagmaGS
 
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper:  Association of Molecular Pathology v. Myriad Ge...Merchant & Gould Whitepaper:  Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Gary M. Myles, Ph.D.
 
Biotechnology Patent Eligibility
Biotechnology Patent EligibilityBiotechnology Patent Eligibility
Biotechnology Patent Eligibility
Gary M. Myles, Ph.D.
 
Patentability Of Microorganisms
Patentability Of MicroorganismsPatentability Of Microorganisms
Patentability Of MicroorganismsShradha Diwan
 
Guidance on Informed Consent FDA_Williamson
Guidance on Informed Consent FDA_WilliamsonGuidance on Informed Consent FDA_Williamson
Guidance on Informed Consent FDA_WilliamsonKirk Williamson, MPH
 
智財法第八組期末報告V1.2
智財法第八組期末報告V1.2智財法第八組期末報告V1.2
智財法第八組期末報告V1.2Hsien-Yung Yi
 
IPR Patentability of gene AMP vs Myriad gene patenting.pptx
IPR Patentability of gene AMP vs Myriad gene patenting.pptxIPR Patentability of gene AMP vs Myriad gene patenting.pptx
IPR Patentability of gene AMP vs Myriad gene patenting.pptx
AATHILAKSHMI URUMANATHAN
 
11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx
ssuserdf29f0
 
CASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosCASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosGary M. Myles, Ph.D.
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environment
Arete-Zoe, LLC
 
Assn. for molecular pathology vs. mtriad genetics case study
Assn. for molecular pathology vs. mtriad genetics case studyAssn. for molecular pathology vs. mtriad genetics case study
Assn. for molecular pathology vs. mtriad genetics case study
Altacit Global
 
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 

Similar to Ownership Rights:: Patents for Derivatives of the Human Body (20)

Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...
Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...
Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetic...
 
Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
Ethics and the Law: The Case of Myriad Genetics, Ethics in Patenting and Eth...
 
Stem Cell Ethics .pptx
Stem Cell Ethics .pptxStem Cell Ethics .pptx
Stem Cell Ethics .pptx
 
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENESTHE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
THE FRONTIERS OF MONOPOLIZATION OF HUMAN GENES
 
Genomics privacy
Genomics privacyGenomics privacy
Genomics privacy
 
Ethics And The Human Genome Project
Ethics And The Human Genome ProjectEthics And The Human Genome Project
Ethics And The Human Genome Project
 
AMP vs. USPTO
AMP vs. USPTOAMP vs. USPTO
AMP vs. USPTO
 
Nagma(patenting of genes)
Nagma(patenting of genes)Nagma(patenting of genes)
Nagma(patenting of genes)
 
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper:  Association of Molecular Pathology v. Myriad Ge...Merchant & Gould Whitepaper:  Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
 
Biotechnology Patent Eligibility
Biotechnology Patent EligibilityBiotechnology Patent Eligibility
Biotechnology Patent Eligibility
 
Patentability Of Microorganisms
Patentability Of MicroorganismsPatentability Of Microorganisms
Patentability Of Microorganisms
 
Guidance on Informed Consent FDA_Williamson
Guidance on Informed Consent FDA_WilliamsonGuidance on Informed Consent FDA_Williamson
Guidance on Informed Consent FDA_Williamson
 
智財法第八組期末報告V1.2
智財法第八組期末報告V1.2智財法第八組期末報告V1.2
智財法第八組期末報告V1.2
 
IPR Patentability of gene AMP vs Myriad gene patenting.pptx
IPR Patentability of gene AMP vs Myriad gene patenting.pptxIPR Patentability of gene AMP vs Myriad gene patenting.pptx
IPR Patentability of gene AMP vs Myriad gene patenting.pptx
 
11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx
 
CASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosCASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and Embryos
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environment
 
Assn. for molecular pathology vs. mtriad genetics case study
Assn. for molecular pathology vs. mtriad genetics case studyAssn. for molecular pathology vs. mtriad genetics case study
Assn. for molecular pathology vs. mtriad genetics case study
 
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
Cesar Palacios-Gonzales, "Regulation and Ethics of MRTs"
 
10420140501002 2
10420140501002 210420140501002 2
10420140501002 2
 

Recently uploaded

GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
CatarinaPereira64715
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
Fwdays
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
Product School
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
DanBrown980551
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Ramesh Iyer
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
91mobiles
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Inflectra
 

Recently uploaded (20)

GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
 

Ownership Rights:: Patents for Derivatives of the Human Body

  • 1. Issues for Today and Tomorrow Ownership Rights: Patents for Derivatives of the Human Body Larnita Pette May 19, 2009 (Updated December 2011)
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.

Editor's Notes

  1. Australia Whose DNA .pdf, Tonga & Iceland, Biotech, Ownership and Consent Indigenous peoples and culturally appropriate informed consent and ownership of DNA. Genomic studies are also being undertaken with populations which do not identify themselves as indigenous peoples, such as the UK, Norfolk Island, Mormons and in Iceland. Such populations are sometimes targeted because they have well documented genealogical histories, making them valuable for tracing inherited diseases. In Iceland availability of genealogies date back centuries. Informed consent claimed through an act of parliament. decode a commercial firm. October 1999, Autogen Ltd announced an agreement in principle to form a strategic alliance with Merck Lipha, a subsidiary of Merck Kga A of Darmstadt, Germany the manufacturer of metformin the world’s top selling drug for the treatment of diabetes. Metformin holds 50% of the market for the treatment of Type 2 Diabetes in Australia.- introduced to the US market in 1996, where it became the #1 best seller. Object of Autogen/Merck Human Genetics Project is discovery of human genes involved in weight imbalance, Type 2 Diabetes and insulin resistance. Details of deal to share compensation with the Tongan people and the catch which caused Autogen to abandon research on TANIS gene
  2. Who Owns Your Body The California Supreme Court agreed that Moore did have a claim for breach of fiduciary duty and lack of informed consent because Dr. Golde had failed to disclose the extent of his research and his economic interest in Moore’s cells. The court stated in its decision, that an adult of sound mind has the right to exercise control over his own body and, within that right, should have the power of deciding whether or not to submit to lawful medical treatment. For that power to be effective, the court stated, a patient’s consent must be informed consent. The Florida district court did find that Matalon and his group had unjustly benefited from the licensing fees negotiated under the commercial patent. However, the Florida court also ruled that the case involved no patient-physician relationship—because Dr. Matalon was not a treating physician to the Canavan patients or their families—and thus found no breach of duty of informed consent. The case of Washington University v. Catalona highlights the reality, that researchers themselves have limited rights over their own work, and provides a focal point by which to explore the question: How does informed consent grant a researcher the right to explore one’s biological materials in the name of science, and does it strip consenting patients of all interests in something that is uniquely their own? The district court found that WU had alone assumed the burden of all legal, regulatory, and compliance risks with respect to all research done in connection with the biorepository that Dr. Catalona had helped to create. The court found thus that WU had, at all times, exercised undisputed and exclusive possession over the samples in question, demonstrating prima facie evidence of ownership. The court ruled that the samples were donated to WU as gifts and donors had no ownership interest in those samples. Dr. Catalona appealed the decision.